We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
-24.42%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.44B
AUM Growth
-$733M
(-34%)
Cap. Flow
-$124M
Cap. Flow
% of AUM
-8.58%
Top 10 Holdings %
Top 10 Hldgs %
26.07%
Holding
366
New
63
Increased
73
Reduced
132
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$42.5M |
| 2 |
Valvoline
VVV
|
+$33.1M |
| 3 |
Hershey
HSY
|
+$28.9M |
| 4 |
Avnet
AVT
|
+$27.6M |
| 5 |
Zurn Elkay Water Solutions
ZWS
|
+$25.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lamar Advertising Co
LAMR
|
+$39.2M |
| 2 |
Huntington Bancshares
HBAN
|
+$34.7M |
| 3 |
Acushnet Holdings
GOLF
|
+$29.8M |
| 4 |
Jack in the Box
JACK
|
+$29M |
| 5 |
Verizon
VZ
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.82% |
| 2 | Financials | 17.59% |
| 3 | Industrials | 12.93% |
| 4 | Technology | 12.58% |
| 5 | Healthcare | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Ormat Technologies
ORA
$6.19B
| $455K | 0.03% |
+6,724
| New | +$507K |
|
|
IGMS
202
DELISTED
IGM Biosciences
IGMS
| $452K | 0.03% |
+8,046
| New | +$353K |
|
203
Insulet
PODD
$11.5B
| $448K | 0.03% |
2,705
-1,478
| -35% | -$270K |
|
|
ONEM
204
DELISTED
1Life Healthcare
ONEM
| $447K | 0.03% |
+24,615
| New | +$540K |
|
205
Guardant Health
GH
$19.4B
| $444K | 0.03% |
6,385
-8,882
| -58% | -$682K |
|
|
MYOK
206
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $443K | 0.03% |
+9,440
| New | +$605K |
|
207
Trex
TREX
$4.57B
| $442K | 0.03% |
+11,028
| New | +$517K |
|
208
Tenet Healthcare
THC
$21.1B
| $435K | 0.03% |
30,220
-7,793
| -21% | -$224K |
|
209
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.87B
| $432K | 0.03% |
+21,142
| New | +$668K |
|
210
Visteon
VC
$2.79B
| $425K | 0.03% |
8,851
-1,327
| -13% | -$96.3K |
|
|
DOCU
211
DocuSign
DOCU
$10.3B
| $421K | 0.03% |
4,559
-2,162
| -32% | -$174K |
|
212
Denali Therapeutics
DNLI
$3.76B
| $416K | 0.03% |
+23,776
| New | +$496K |
|
213
US Foods
USFD
$21.8B
| $410K | 0.03% |
23,170
-14,235
| -38% | -$477K |
|
214
XPO
XPO
$24.2B
| $410K | 0.03% |
24,337
+2,773
| +13% | +$74.1K |
|
215
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
| $403K | 0.03% |
5,712
-1,799
| -24% | -$122K |
|
|
SWCH
216
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $385K | 0.03% |
26,701
-1,415
| -5% | -$21.5K |
|
217
Houlihan Lokey
HLI
$9.8B
| $382K | 0.03% |
+7,331
| New | +$380K |
|
218
Wayfair
W
$12.2B
| $380K | 0.03% |
+7,114
| New | +$544K |
|
219
Lam Research
LRCX
$359B
| $373K | 0.03% |
15,530
-6,120
| -28% | -$176K |
|
220
Enphase Energy
ENPH
$4.89B
| $369K | 0.03% |
+11,425
| New | +$431K |
|
|
XYZ
221
Block Inc
XYZ
$47.5B
| $364K | 0.03% |
+6,957
| New | +$476K |
|
222
Quanterix
QTRX
$175M
| $360K | 0.03% |
19,619
-11,191
| -36% | -$255K |
|
223
Axsome Therapeutics
AXSM
$12.4B
| $353K | 0.02% |
+6,006
| New | +$489K |
|
|
NVO
224
Novo Nordisk
NVO
$219B
| $353K | 0.02% |
11,718
-692
| -6% | -$20.6K |
|
225
PennantPark Floating Rate Capital
PFLT
$695M
| $350K | 0.02% |
71,946
-450
| -0.6% | -$4.71K |
|
Similar funds
VFG
SLG
KCP
UAG
PS
RPAM
BBI
SSG
Advisory Research's Q1 2020 Portfolio in Review
As of Q1 2020, Advisory Research held 366 positions worth $1.44B, down 34% from $2.18B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Advisory Research withdrew a net $124M in Q1 2020, closing 88 positions and reducing 132 holdings. Its most notable exit was Lamar Advertising Co, an estimated $39.2M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.
Against the trend, Advisory Research opened a new position in Hershey worth $26M.
- Advisory Research's largest Q1 2020 buy was Hershey: 196,008 shares worth $26M.
- Advisory Research added most to Microsoft in Q1 2020, an estimated $42.5M increase.
- Advisory Research's biggest Q1 2020 reduction was Verizon, cutting an estimated $27.8M.
- Advisory Research fully exited Lamar Advertising Co in Q1 2020, selling an estimated $39.2M.
- Advisory Research's ten largest holdings make up 26% of its $1.44B portfolio in Q1 2020.
- Advisory Research opened 63 new positions and closed 88 in Q1 2020.
- Advisory Research's portfolio value fell 34% quarter-over-quarter to $1.44B.
Based on Advisory Research's 13F filing for Q1 2020, filed 12 May 2020.